With the analysis among 492 patents, we discovered top 182 key players by total patent application. Shanghai Biowindow Gene Development Co. Ltd., Ironwood Pharmaceuticals, Inc., F. Hoffmann-La Roche Ltd. are dominant in this area. They take 25.41% of the total patent filing.
Shanghai Biowindow Gene Development Co. Ltd.
Shanghai Shi, China
Patent: 68
Ironwood Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 33
F. Hoffmann-La Roche Ltd.
Daewoong Pharmaceutical Co., Ltd.
New Jersey, United States
Patent: 9
Sumitomo Pharmaceuticals Co., Ltd.
Pennsylvania, United States
Patent: 7
Merz Pharma GmbH & Co. KGaA
Sachsen, Germany
Patent: 7
Nordrhein-Westfalen, Germany
Patent: 7
DuPont Pharmaceuticals Co.
Delaware, United States
Patent: 7
With the analysis among 7 patents, we discovered top 6 start-ups by total patent application. Cellix Bio Pvt Ltd., Biosplice Therapeutics, Inc., Institut National de la Santé et de la Recherche Médicale are active in this area.
Telangana, India
Patent: 2
Biosplice Therapeutics, Inc.
California, United States
Patent: 1
Institut National de la Santé et de la Recherche Médicale
Basel-Landschaft, Switzerland
Patent: 1
Hyogo-ken, Japan
Patent: 1
Disarm Therapeutics, Inc.
Massachusetts, United States
Patent: 1
With the analysis among related 63 patents applied in the last 5 years. We discover 45 most active companies in this area. The fast-growing Artivila Therapeutics, University of Bordeaux 1, Centre National De La Recherche Scientif take 17.46% of patent filing during this period.
Jiangsu Sheng, China
Patent: 5
Bretagne, France
Patent: 3
Centre National De La Recherche Scientif
Wuhan Siling Biotechnology Co., Ltd.
Hubei Sheng, China
Patent: 2
The University of Sheffield
SHEFFIELD, United Kingdom
Patent: 2
Wuhan Jiayu Technology Co Ltd
Hubei Sheng, China
Patent: 2
Chengdu Chuangyi Vision Technology Co., Ltd.
Sichuan Sheng, China
Patent: 2
Neurocrine Biosciences, Inc.
California, United States
Patent: 1
Yissum Research Development Co. Ltd.
Shijiazhuang Yiling Pharmaceutical Co., Ltd.
Hebei Sheng, China
Patent: 1
With the analysis among related 63 patents in last 5 years, we discover 38 new entrants. Artivila Therapeutics, University of Bordeaux 1, Centre National De La Recherche Scientif are the most active new entrants in this area.
Jiangsu Sheng, China
Patent: 5
Bretagne, France
Patent: 3
Centre National De La Recherche Scientif
Wuhan Siling Biotechnology Co., Ltd.
Hubei Sheng, China
Patent: 2
The University of Sheffield
SHEFFIELD, United Kingdom
Patent: 2
Wuhan Jiayu Technology Co Ltd
Hubei Sheng, China
Patent: 2
Chengdu Chuangyi Vision Technology Co., Ltd.
Sichuan Sheng, China
Patent: 2
Neurocrine Biosciences, Inc.
California, United States
Patent: 1
Shijiazhuang Yiling Pharmaceutical Co., Ltd.
Hebei Sheng, China
Patent: 1
National Research Institute of Chinese Medicine
With the analysis among 125 patents, we discovered top 50 universities and scientific research institutions by total patent application. Washington University in St. Louis, Chiba University, Georgetown University School of Medicine are dominant in this area. They take 14.40% of the total patent filing.
Washington University in St. Louis
Missouri, United States
Patent: 6
Chiba-ken, Japan
Patent: 6
Georgetown University School of Medicine
District of Columbia, United States
Patent: 6
The Johns Hopkins University
Shanghai Institute of Materia Medica Chinese Academy of Sciences
Shanghai Shi, China
Patent: 4
Illinois, United States
Patent: 3
Beijing Shi, China
Patent: 3
Xi'an Jiaotong University
Shaanxi Sheng, China
Patent: 3
Shanghai Shi, China
Patent: 3
Jiangsu Sheng, China
Patent: 3